CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Prosomnus Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Prosomnus Inc
5675 Gibraltar Drive
PLEASANTON, CA  94588  United States Fax: (302) 636-5454f:302 636-5454
Emerged from Bankruptcy on 8/5/2024
This company ceased filing statements with the SEC on 8/5/2024.
This company is no longer actively traded on any major stock exchange.
Business Summary
ProSomnus, Inc. is a medical technology company. The Company is focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Its intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. The Company's devices have demonstrated efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. Its precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYesYes-Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
6770 Blank checks
3843 Dental equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board Laing F.Rikkers 12/6/2022 12/6/2022
Chief Executive Officer, Director LeonardLiptak 48 12/6/2022 12/6/2022
Chief Financial Officer, Principal Accounting Officer BrianDow 53 3/1/2023 3/1/2023
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ProSomnus Sleep Technologies, Inc. 5675 Gibralter Drive Pleasanton CA United States

Business Names
Business Name
LAAA
LAAA Merger Corp
LAAAU
5 additional Business Names available in full report.

General Information
Outstanding Shares: 17,394,064 (As of 7/29/2024)
Shareholders: 363
Stock Exchange: OTC
Federal Tax Id: 882978216
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024